The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Predictive Biomarkers Market Research Report 2025
Synopsis
Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.
The global Predictive Biomarkers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer.
This report aims to provide a comprehensive presentation of the global market for Predictive Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predictive Biomarkers.
Report Scope
The Predictive Biomarkers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Predictive Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Predictive Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens Healthcare
Roche Diagnostic
G.E. Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
Segment by Type
Cancer
Neurological Disorder
Cardiovascular Disorder
Immunological Disorder
Others
Segment by Application
Diagnostic Centers
Academic Research Institutes
CRO’S
Bio-Pharmaceutical Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Predictive Biomarkers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.
The global Predictive Biomarkers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer.
This report aims to provide a comprehensive presentation of the global market for Predictive Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predictive Biomarkers.
Report Scope
The Predictive Biomarkers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Predictive Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Predictive Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens Healthcare
Roche Diagnostic
G.E. Healthcare
Abbott Laboratories
Qiagen
Johnson and Johnson
Segment by Type
Cancer
Neurological Disorder
Cardiovascular Disorder
Immunological Disorder
Others
Segment by Application
Diagnostic Centers
Academic Research Institutes
CRO’S
Bio-Pharmaceutical Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Predictive Biomarkers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Predictive Biomarkers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cancer
1.2.3 Neurological Disorder
1.2.4 Cardiovascular Disorder
1.2.5 Immunological Disorder
1.2.6 Others
1.3 Market by Application
1.3.1 Global Predictive Biomarkers Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Centers
1.3.3 Academic Research Institutes
1.3.4 CRO’S
1.3.5 Bio-Pharmaceutical Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Predictive Biomarkers Market Perspective (2019-2030)
2.2 Predictive Biomarkers Growth Trends by Region
2.2.1 Global Predictive Biomarkers Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Predictive Biomarkers Historic Market Size by Region (2019-2024)
2.2.3 Predictive Biomarkers Forecasted Market Size by Region (2025-2030)
2.3 Predictive Biomarkers Market Dynamics
2.3.1 Predictive Biomarkers Industry Trends
2.3.2 Predictive Biomarkers Market Drivers
2.3.3 Predictive Biomarkers Market Challenges
2.3.4 Predictive Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Predictive Biomarkers Players by Revenue
3.1.1 Global Top Predictive Biomarkers Players by Revenue (2019-2024)
3.1.2 Global Predictive Biomarkers Revenue Market Share by Players (2019-2024)
3.2 Global Predictive Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Predictive Biomarkers Revenue
3.4 Global Predictive Biomarkers Market Concentration Ratio
3.4.1 Global Predictive Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Predictive Biomarkers Revenue in 2023
3.5 Predictive Biomarkers Key Players Head office and Area Served
3.6 Key Players Predictive Biomarkers Product Solution and Service
3.7 Date of Enter into Predictive Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Predictive Biomarkers Breakdown Data by Type
4.1 Global Predictive Biomarkers Historic Market Size by Type (2019-2024)
4.2 Global Predictive Biomarkers Forecasted Market Size by Type (2025-2030)
5 Predictive Biomarkers Breakdown Data by Application
5.1 Global Predictive Biomarkers Historic Market Size by Application (2019-2024)
5.2 Global Predictive Biomarkers Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Predictive Biomarkers Market Size (2019-2030)
6.2 North America Predictive Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Predictive Biomarkers Market Size by Country (2019-2024)
6.4 North America Predictive Biomarkers Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Predictive Biomarkers Market Size (2019-2030)
7.2 Europe Predictive Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Predictive Biomarkers Market Size by Country (2019-2024)
7.4 Europe Predictive Biomarkers Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Predictive Biomarkers Market Size (2019-2030)
8.2 Asia-Pacific Predictive Biomarkers Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Predictive Biomarkers Market Size by Region (2019-2024)
8.4 Asia-Pacific Predictive Biomarkers Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Predictive Biomarkers Market Size (2019-2030)
9.2 Latin America Predictive Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Predictive Biomarkers Market Size by Country (2019-2024)
9.4 Latin America Predictive Biomarkers Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Predictive Biomarkers Market Size (2019-2030)
10.2 Middle East & Africa Predictive Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Predictive Biomarkers Market Size by Country (2019-2024)
10.4 Middle East & Africa Predictive Biomarkers Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens Healthcare
11.1.1 Siemens Healthcare Company Detail
11.1.2 Siemens Healthcare Business Overview
11.1.3 Siemens Healthcare Predictive Biomarkers Introduction
11.1.4 Siemens Healthcare Revenue in Predictive Biomarkers Business (2019-2024)
11.1.5 Siemens Healthcare Recent Development
11.2 Roche Diagnostic
11.2.1 Roche Diagnostic Company Detail
11.2.2 Roche Diagnostic Business Overview
11.2.3 Roche Diagnostic Predictive Biomarkers Introduction
11.2.4 Roche Diagnostic Revenue in Predictive Biomarkers Business (2019-2024)
11.2.5 Roche Diagnostic Recent Development
11.3 G.E. Healthcare
11.3.1 G.E. Healthcare Company Detail
11.3.2 G.E. Healthcare Business Overview
11.3.3 G.E. Healthcare Predictive Biomarkers Introduction
11.3.4 G.E. Healthcare Revenue in Predictive Biomarkers Business (2019-2024)
11.3.5 G.E. Healthcare Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Predictive Biomarkers Introduction
11.4.4 Abbott Laboratories Revenue in Predictive Biomarkers Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Predictive Biomarkers Introduction
11.5.4 Qiagen Revenue in Predictive Biomarkers Business (2019-2024)
11.5.5 Qiagen Recent Development
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Detail
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Predictive Biomarkers Introduction
11.6.4 Johnson and Johnson Revenue in Predictive Biomarkers Business (2019-2024)
11.6.5 Johnson and Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
